AzTrials
AzTrials

EndometriosisENDO-DIETNCT05387161

Evaluation of Nutritional Status, Eating Habits and Improvement of Symptoms With a Nutritional Intervention in Women With enDometriosis

An observational study of Endometriosis, run by University of Pavia at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to investigate the nutritional status and eating habits of women suffering from endometriosis and chronic pelvic pain in relation to describe the possible improvement of clinical symptoms following a nutritional intervention. Read more about this study

Who is it for?
Ages 18 to 55 years, women only
Conditions the study is for
Endometriosis
What is being tested?
Nutritional intervention
How many people
65 participants
Where
1 siteItaly
Study dates
1 Sep 2020to 30 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: All patients referred to the Endometriosis Outpatient Clinic of the Gynecological Clinic of the San Matteo Polyclinic in Pavia will be enrolled and will agree to participate in the study and have signed the relative informed consent.

Who may be able to join

  • Clinical diagnosis of endometriosis +/- chronic pelvic pain
  • No menopause (at least 1 menstrual cycle in the previous 6 months)
  • Informed consent from the patient and / or an authorized legal representative

Who cannot join

  • Postmenopause
  • Pregnancy
  • Hysterectomy or oophorectomy
  • Chronic diseases that affect the gastrointestinal absorption of nutrients (celiac disease, Chron's disease, ulcerative colitis, cystic fibrosis)
  • History of kidney stones, cancer (except basal cell carcinoma) or diabetes
  • Modification in the course of the therapeutic intervention of the therapy for endometriosis

Trial locations and contacts

1 site in 1 country.

Cinzia Ferraris, PhD contact

3402337242

cinzia.ferraris@unipv.it

Italy1 site, 1 recruiting
  • University of Pavia

    Pavia, 27100

    Cinzia Ferraris, PhD, +39 0382987868, cinzia.ferraris@unipv.it

    Barbara Gardella, Dott.

    Recruiting

Other trials in Italy

About this study

Official title: Evaluation of Nutritional Status, Eating Habits and Improvement of Symptoms With a Nutritional Intervention in Women With enDometriosis and chrOnic Pelvic Pain

The study aims to investigate the nutritional status and eating habits of women suffering from endometriosis and chronic pelvic pain in relation to describe the possible improvement of clinical symptoms following a nutritional intervention.

The primary aim is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain.

Read more

The first secondary aim will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some specific areas of the patients (sexual, psychological) together with the quantification of some routine blood chemistry parameters (inflammatory markers, levels of proteins and vitamins) .

The second secondary objective will be aimed at describing the changes in clinical symptoms and the parameters mentioned above in patients based on the severity/stage of the pathologies under study.

Conditions
Endometriosis
Being tested
Nutritional intervention
Keywords
endometriosis, diet, inflammation, chronic pelvic pain
Medical subject headings
Endometriosis, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nutritional interventionOther

    The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative ungrammatical daily diet plan, which must be followed for the entire period of intervention (6 months).

Study groups in NCT05387161
Study groupRoleWhat they receive
Observational groupA nutritional assessment will be held with the detection of anthropometric parameters. Each participant will be asked to fill in the SF36, the VAS scales, the KESS questionnaire, the SFFI questionnaire, the Questionnaire PUF and O'Leary/Santn, the BDI and the TAS for an assessment of the psychological component. In addition, patients will be asked to fill in a FFQ of food consumption and a 7 days food diary. Finally, routine blood chemistry tests will also be performed, to which will be added those for measuring the inflammatory state and stool examination for the evaluation of fecal Calprotectin for the measurement of intestinal inflammatory markers. The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative daily diet plan, which must be followed for 6 months. At the end of the 6 months, all anthropometric assessments, blood chemistry and stool tests will be repeated, together with the questionnaires.
Receives: Other: Nutritional intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain.

    The outcome will be assessed with repeated measurements using the following parameters:

    -Evaluation of chronic pelvic pain, dysmenorrhea, dyschezia and dysuria: VAS visual analogue scale, from 0 to 10 points where 10 points indicates worst pain

    Measured: 6 months

  2. The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (quality of life) in women suffering from endometriosis with chronic pelvic pain.

    The outcome will be assessed with repeated measurements using the following parameters:

    Quality of life: measurement of physical and mental components with SF36 consisting of two components, one physical and one mental. Both fall within a range from 0 to 100 points where higher values are associated with better health

    Measured: 6 months

  3. The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (intestinal function) in women suffering from endometriosis with chronic pelvic pain.

    The outcome will be assessed with repeated measurements using the following parameters:

    Bowel Function: Knowles-Eccersley-Scott Symptom Questionnaire (KESS) (points)

    Measured: 6 months

Secondary outcomes (8)
  1. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Sexual Function

    The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire:

    Sexual Function: FSFI questionnaire (points)

    Measured: 6 months

  2. To describe and evaluate the impact of the nutritional intervention by describing the changes in Urinary function and bladder pain

    The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire:

    Urinary function and bladder pain: PUF and O's Leary / Sant questionnaire (points)

    Measured: 6 months

  3. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component about Depression

    The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire:

    Beck Depression Inventory (BDI) (points)

    Measured: 6 months

  4. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component

    The outcomes necessary to respond to the secondary objective are the administration of the following questionnaires:

    Alexithymia Scale (TAS) questionnaire (points)

    Measured: 6 months

  5. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some routine blood chemistry parameters

    The outcomes necessary to respond to the secondary objective are the administration of the following routine blood chemistry parameters:

    Measure Ca125 (unità/ml) and Vitamin D (ng/ml)

    Measured: 6 months

  6. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Intestinal inflammatory marker

    The outcomes necessary to respond to the secondary objective are the administration of the following test:

    fecal calprotectin (mg/kg)

    Measured: 6 months

  7. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some Inflammatory markers

    The outcomes necessary to respond to the secondary objective are the administration of the following Inflammatory markers: IL-6 and IL-1β values (pg/ml)

    Measured: 6 months

  8. The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in measurement of proteins

    The outcomes necessary to respond to the secondary objective are the administration of the following measurement of proteins: C-reactive protein values (mg/dL)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2022
  2. Study start1 Sep 2020
  3. Primary completion30 Dec 2023 (estimated)
  4. Study completion30 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
65 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05387161
Sponsor's protocol ID
2021-ENDODIET
Acronym
ENDO-DIET
Status last verified
May 2023
First submitted
24 Jan 2022
Last updated
11 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Endometriosis, run by University of Pavia at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Cinzia Ferraris, PhD (3402337242, cinzia.ferraris@unipv.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain. (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2023; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in